Prima Mente

Prima Mente is a biotechnology company developing large-scale biological foundation models to understand and detect neurodegenerative disease.

The company generates proprietary multi-omic data including whole-epigenome sequencing, and trains transformer-based models on DNA methylation patterns in cell-free DNA to enable non-invasive detection and molecular stratification of conditions including Alzheimer's disease and Parkinson's disease from blood samples.

Its models are being validated in a longitudinal clinical study running across NHS sites in the United Kingdom.